Investigation of the Relationship between CMYC Gene Polymorphisms and Glioma Susceptibility in Chinese Children

References

• Wang H, Wu J, Guo W. SP1-Mediated Upregulation of lncRNA LINC01614 Functions a ceRNA for miR-383 to Facilitate Glioma Progression Through Regulation of ADAM12. Onco Targets Ther. 2020;13:4305–18. doi:https://doi.org/10.2147/OTT.S242854.
   PubMed Web of Science ®Google Scholar
• Li X-Y, Huang G-H, Liu Q-K, Yang X-T, Wang K, Luo W-Z, et al. Porf-2 Inhibits Tumor Cell Migration Through the MMP-2/9 Signaling Pathway in Neuroblastoma and Glioma. Front Oncol. 2020;10:975. doi:https://doi.org/10.3389/fonc.2020.00975.
   PubMed Web of Science ®Google Scholar
• Zhao B, Meng L-Q, Huang H-N, Pan Y, Xu Q-Q. A novel functional polymorphism, 16974 A/C, in the interleukin-12-3' untranslated region is associated with risk of glioma. DNA Cell Biol. 2009;28(7):335–41. doi:https://doi.org/10.1089/dna.2008.0845.
   PubMed Web of Science ®Google Scholar
• Chang C-Y, Pan P-H, Li J-R, Ou Y-C, Wang J-D, Liao S-L, et al. Aspirin induced glioma apoptosis through Noxa Upregulation. Int J Mol Sci. 2020;21(12):4219. doi:https://doi.org/10.3390/ijms21124219.
   Web of Science ®Google Scholar
• Zhang Q, Zhong H, Fan Y, Liu Q, Song J, Yao S, et al. Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis. Front Bioeng Biotechnol. 2020;8:592. doi:https://doi.org/10.3389/fbioe.2020.00592.
   PubMed Web of Science ®Google Scholar
• Wang F, Zhou Y, Cheng S, Lou J, Zhang X, He Q, et al. Gint4.T-Modified DNA Tetrahedrons Loaded with Doxorubicin Inhibits Glioma Cell Proliferation by Targeting PDGFRβ. Nanoscale Res Lett. 2020;15(1):150. doi:https://doi.org/10.1186/s11671-020-03377-y.
   PubMed Web of Science ®Google Scholar
• Xiao L, Li X, Mu Z, Zhou J, Zhou P, Xie C, et al. FTO inhibition enhances the Antitumor Effect of Temozolomide by Targeting MYC-miR-155/23a Cluster-MXI1 Feedback Circuit in Glioma . Cancer Res. 2020;80(18):3945–58. doi:https://doi.org/10.1158/0008-5472.
   PubMed Web of Science ®Google Scholar
• Cai H, Liu W, Liu X, Li Z, Feng T, Xue Y, et al. Advances and prospects of vasculogenic mimicry in glioma: a potential new therapeutic target? Onco Targets Ther. 2020;13:4473–83. doi:https://doi.org/10.2147/OTT.S247855.
   PubMed Web of Science ®Google Scholar
• Li Y, et al. Downregulation of LUZP2 is correlated with poor prognosis of low-grade glioma. Biomed Res Int. 2020;2020:9716720.
   PubMed Web of Science ®Google Scholar
• Yuan J, Zhang N, Zheng Y, Chen Y-D, Liu J, Yang M, et al. LncRNA GAS5 indel genetic polymorphism contributes to glioma risk through interfering binding of transcriptional factor TFAP2A. DNA Cell Biol. 2018;37(9):750–7. doi:https://doi.org/10.1089/dna.2018.4215.
   PubMed Web of Science ®Google Scholar
• da Silveira F. d C A, Lopes B. d A, da Fonseca CO, Quirico-Santos T, de Palmer Paixão ICN, de Amorim L. M d F, et al. Analysis of EGF + 61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy. J Cancer Res Clin Oncol. 2012;138(8):1347–54. doi:https://doi.org/10.1007/s00432-012-1203-5.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhao T, Li L, Xu C, Zhang X, Tse V, et al. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population. DNA Cell Biol. 2012;31(6):1107–13. doi:https://doi.org/10.1089/dna.2011.1521.
   PubMed Web of Science ®Google Scholar
• Permuth-Wey J, Thompson RC, Burton Nabors L, Olson JJ, Browning JE, Madden MH, et al. A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma. J Neurooncol. 2011;105(3):639–46. doi:https://doi.org/10.1007/s11060-011-0634-1.
   PubMed Web of Science ®Google Scholar
• Dou T, Wu Q, Chen X, Ribas J, Ni X, Tang C, et al. A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population. J Cancer Res Clin Oncol. 2010;136(12):1853–9. doi:https://doi.org/10.1007/s00432-010-0844-5.
   PubMed Web of Science ®Google Scholar
• Chen P, Wiencke J, Aldape K, Kesler-Diaz A, Miike R, Kelsey K, et al. Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev. 2000;9(8):843–7.
   PubMed Web of Science ®Google Scholar
• Zhang L, Qiu Z, Luo J, Shu W. X-ray repair cross-complementing gene 1 Arg399Gln polymorphism and glioma risk among Asians: A meta-analysis based on 2 326 cases and 3 610 controls. Neural Regen Res. 2012;7(29):2313–9. doi:https://doi.org/10.3969/j.issn.1673-5374.2012.29.011.
   PubMed Web of Science ®Google Scholar
• Xu H, Chai S, Wang Y, Wang J, Xiao D, Li J, et al. Molecular and clinical characterization of PARP9 in gliomas: A potential immunotherapeutic target. CNS Neurosci Ther. 2020;26(8):804–14. doi:https://doi.org/10.1111/cns.13380.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhou L, Nan Z, Yuan Q, Wen J, Xu M, et al. Knockdown of c‐Myc activates Fas-mediated apoptosis and sensitizes A549 cells to radiation . Oncol Rep. 2017;38(4):2471–9. doi:https://doi.org/10.3892/or.2017.5897.
   PubMed Web of Science ®Google Scholar
• Dong H, Adams NM, Xu Y, Cao J, Allan DSJ, Carlyle JR, et al. The IRE1 endoplasmic reticulum stress sensor activates natural killer cell immunity in part by regulating c-Myc. Nat Immunol. 2019;20(7):865–78. doi:https://doi.org/10.1038/s41590-019-0388-z.
   PubMed Web of Science ®Google Scholar
• Xu L, Wang L, Zhou L, Dorfman RG, Pan Y, Tang D, et al. The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming. Neoplasia. 2019;21(5):429–41. doi:https://doi.org/10.1016/j.neo.2019.03.002.
   PubMed Web of Science ®Google Scholar
• Basit F, Andersson M, Hultquist A. The Myc/Max/Mxd Network Is a Target of Mutated Flt3 Signaling in Hematopoietic Stem Cells in Flt3-ITD-Induced Myeloproliferative Disease. Stem Cells Int. 2018;2018:3286949. doi:https://doi.org/10.1155/2018/3286949.
   PubMed Web of Science ®Google Scholar
• Lee Y-S, Heo W, Son C-H, Kang C-D, Park Y-S, Bae J, et al. Upregulation of Myc promotes the evasion of NK cell‐mediated immunity through suppression of NKG2D ligands in K562 cells. Mol Med Rep. 2019;20(4):3301–7. doi:https://doi.org/10.3892/mmr.2019.10583.
   PubMed Web of Science ®Google Scholar
• Qin Y, Hu Q, Xu J, Ji S, Dai W, Liu W, et al. PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis. Cell Commun Signal. 2019;17(1):30. doi:https://doi.org/10.1186/s12964-019-0344-4.
   PubMedGoogle Scholar
• Loftus RM, Assmann N, Kedia-Mehta N, O'Brien KL, Garcia A, Gillespie C, et al. Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice. Nat Commun. 2018;9(1):2341. doi:https://doi.org/10.1038/s41467-018-04719-2.
   PubMed Web of Science ®Google Scholar
• Su B, Xu T, Bruce JP, Yip KW, Zhang N, Huang Z, et al. hsa‐miR‐24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c‐Myc/epithelial‐mesenchymal transition axis. Oncol Rep. 2018;40(5):2536–46. doi:https://doi.org/10.3892/or.2018.6690.
   PubMed Web of Science ®Google Scholar
• Sakr HI, Chute DJ, Nasr C, Sturgis CD. cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis. Diagn Pathol. 2017;12(1):71. doi:https://doi.org/10.1186/s13000-017-0661-0.
   PubMedGoogle Scholar
• Huang X, Zhao J, Fu W, Zhu J, Lou S, Tian X, et al. The association of RAN and RANBP2 gene polymerphisms with Wilms tumor risk in Chinese children. J Cancer. 2020;11(4):804–9. doi:https://doi.org/10.7150/jca.36651.
   PubMed Web of Science ®Google Scholar
• Cheng J, Zhuo Z, Xin Y, Zhao P, Yang W, Zhou H, et al. Relevance of XPD polymorphisms to neuroblastoma risk in Chinese children: a four-center case-control study. Aging. 2018;10(8):1989–2000. doi:https://doi.org/10.18632/aging.101522.
   PubMedGoogle Scholar
• Liu J, Hua R-X, Fu W, Zhu J, Jia W, Zhang J, et al. MYC gene associated polymorphisms and Wilms tumor risk in Chinese children: a four-center case-control study. Ann Transl Med. 2019;7(18):475. doi:https://doi.org/10.21037/atm.2019.08.31.
   PubMed Web of Science ®Google Scholar
• Pan J, Zhu J, Wang M, Yang T, Hu C, Yang J, et al. Association of MYC gene polymorphisms with neuroblastoma risk in Chinese children: A four-center case-control study. J Gene Med. 2020;22(8):e3190. doi:https://doi.org/10.1002/jgm.3190.
   PubMed Web of Science ®Google Scholar
• Yang T, Wen Y, Li J, Tan T, Yang J, Pan J, et al. Association of CMYC polymorphisms with hepatoblastoma risk. Transl Cancer Res Tcr. 2020;9(2):849–55. doi:https://doi.org/10.21037/tcr.2019.12.19.
   Web of Science ®Google Scholar
• Wang J, Zhuo Z, Chen M, Zhu J, Zhao J, Zhang J, et al. RAN/RANBP2 polymorphisms and neuroblastoma risk in Chinese children: a three-center case-control study. Aging. 2018;10(4):808–18. doi:https://doi.org/10.18632/aging.101429.
   PubMedGoogle Scholar
• Hua R-X, Zhuo Z, Ge L, Zhu J, Yuan L, Chen C, et al. LIN28A gene polymorphisms modify neuroblastoma susceptibility: A four-centre case-control study. J Cell Mol Med. 2020;24(1):1059–66. doi:https://doi.org/10.1111/jcmm.14827.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yin J, Xu Q, Shi J. Association between the XPG gene rs2094258 polymorphism and risk of gastric cancer. J Clin Lab Anal. 2018;32(8):e22564. doi:https://doi.org/10.1002/jcla.22564.
   PubMed Web of Science ®Google Scholar
• Chen P, Guo X, Zhang L, Zhang W, Zhou Q, Tian Z, et al. MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN. Oncotarget. 2017;8(3):5206–18. doi:https://doi.org/10.18632/oncotarget.14123.
   PubMedGoogle Scholar
• Day AH, Übler MH, Best HL, Lloyd-Evans E, Mart RJ, Fallis IA, et al. Targeted cell imaging properties of a deep red luminescent iridium(iii) complex conjugated with a c-Myc signal peptide. Chem Sci. 2020;11(6):1599–606. doi:https://doi.org/10.1039/c9sc05568a.
   PubMed Web of Science ®Google Scholar
• Liu Y, Timani K, Mantel C, Fan Y, Hangoc G, Cooper S, et al. TIP110/p110nrb/SART3/p110 regulation of hematopoiesis through CMYC. Blood. 2011;117(21):5643–51. doi:https://doi.org/10.1182/blood-2010-12-325332.
   PubMed Web of Science ®Google Scholar
• Zhong C, Fan L, Li Z, Yao F, Zhao H. SREBP2 is upregulated in esophageal squamous cell carcinoma and co‐operates with c‐Myc to regulate HMGCR expression. Mol Med Rep. 2019;20(4):3003–10. doi:https://doi.org/10.3892/mmr.2019.10577.
   PubMed Web of Science ®Google Scholar
• Luo G, Li B, Duan C, Cheng Y, Xiao B, Yao F, et al. c‐Myc promotes cholangiocarcinoma cells to overcome contact inhibition via the mTOR pathway. Oncol Rep. 2017;38(4):2498–506. doi:https://doi.org/10.3892/or.2017.5913.
   PubMed Web of Science ®Google Scholar
• Zaharieva B, Simon R, Ruiz C, Oeggerli M, Mihatsch MJ, Gasser T, et al. High-throughput tissue microarray analysis of CMYC amplificationin urinary bladder cancer. Int J Cancer. 2005;117(6):952–6. doi:https://doi.org/10.1002/ijc.21253.
   PubMed Web of Science ®Google Scholar
• Berberich A, Schmitt L-M, Pusch S, Hielscher T, Rübmann P, Hucke N, et al. cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastoma. J Neurooncol. 2020;146(1):9–23. doi:https://doi.org/10.1007/s11060-019-03348-z.
   PubMed Web of Science ®Google Scholar
• Odia Y, Orr BA, Bell WR, Eberhart CG, Rodriguez FJ. cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome. J Neurooncol. 2013;115(2):249–59. doi:https://doi.org/10.1007/s11060-013-1221-4.
   PubMed Web of Science ®Google Scholar